Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 16, 2021
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
Vincent Andrews Maintained (CC) at Hold with Increased Target to $30 on, Feb 16th, 2021
Vincent Andrews of Morgan Stanley, Maintained "The Chemours Company" (CC) at Hold with Increased Target from $28 to $30 on, Feb 16th, 2021.
Vincent has made no other calls on CC in the last 4 months.
There are 3 other peers that have a rating on CC. Out of the 3 peers that are also analyzing CC, 1 agrees with Vincent's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Duffy Fischer of "Barclays" Downgraded from Buy to Hold and Increased Target to $28 on, Friday, December 4th, 2020
These are the ratings of the 2 analyists that currently disagree with Vincent
- Arun Viswanathan of "RBC Capital" Upgraded from Hold to Buy and Increased Target to $35 on, Friday, January 8th, 2021
- John McNulty of "BMO Capital" Maintained at Buy with Increased Target to $28 on, Thursday, November 5th, 2020
